ArticleJournal of the American Heart Association2023

Utilization and Outcomes of Primary Prevention Implantable Cardioverter-Defibrillators in Patients With Hypertrophic Cardiomyopathy.

Sarah A Goldstein et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.